BridgeBio Oncology Therapeutics, Inc. Liquidation Value
BBOT
Other
Cash & Equivalents
$373.69M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $373.69M
Total Obligations: -$37.81M
$335.88M
Per share: $4.20
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $373.69M
AR: $0
Total Obligations: -$37.81M
$335.88M
Per share: $4.20
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $373.69M
AR: $0
Inventory: $0
Total Obligations: -$37.81M
$335.88M
Per share: $4.20
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $335.88M | $4.20 |
| Liquid Liquidation Value | $335.88M | $4.20 |
| Operating Liquidation Value | $335.88M | $4.20 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $373.69M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $35.04M |
| Long-term Debt | N/A |
| Op. Lease Liability | $2.77M |
| Finance Lease | N/A |
| Shares Outstanding | 80.0M |
Explore all 195 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $373.69M | N/A | N/A | $1.37M | $35.04M | N/A | $2.77M | N/A |
| 2025-09-30 | $408.74M | N/A | N/A | $3.65M | $35.71M | N/A | $2.89M | N/A |
| 2025-06-30 | $1.33M | N/A | N/A | N/A | $2.63M | N/A | N/A | N/A |
| 2025-03-31 | $1.93M | N/A | N/A | N/A | $1.87M | N/A | N/A | N/A |
▼ Community Notes